semaglutide soul trial oral cardiovascular outcomes results 2025 nejm Heart disease is the #1 cause of death in type 2 diabetes — and for the first time, an GLP-1 drug has been SOUL (Semaglutide cardiOvascular oUtcomes triaL)

All of these things make the price high

Fella Health named two licensed partner pharmacies it works with

GIP may help improve metabolic function and appetite control

Medical conditions linked to obesity and being chronically overweight include major cardiovascular events, including heart attacks and strokes

Canadian patients should verify supplier credentials, confirm independent third-party testing (not just supplier-conducted tests), ensure proper storage conditions during shipping (especially important given Canadian temperature extremes), and understand reconstitution protocols completely before use

Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs